Insider Transactions in Q4 2025 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+11.22%
|
-
|
|
Nov 10
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
1,020
-4.43%
|
$83,640
$82.55 P/Share
|
|
Nov 10
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+4.24%
|
$60,180
$59.26 P/Share
|
|
Nov 10
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,000
-12.85%
|
$1,079,000
$83.16 P/Share
|
|
Nov 10
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+19.73%
|
$767,000
$59.26 P/Share
|